Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of SLAMF1 mRNA | CTD | PMID:23649840 | 1,4-phenylenediamine | decreases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | 4-phenylenediamine results in decreased expression of SLAMF1 mRNA | CTD | PMID:20713136 | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in decreased expression of SLAMF1 mRNA | CTD | PMID:20713136 | 17alpha-ethynylestradiol | affects expression | ISO | Slamf1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SLAMF1 mRNA | CTD | PMID:17555576 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Slamf1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SLAMF1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SLAMF1 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SLAMF1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | SLAMF1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SLAMF1 intron and Aflatoxin B1 results in decreased methylation of SLAMF1 promoter | CTD | PMID:30157460 | aldehydo-D-glucose | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLAMF1 mRNA | CTD | PMID:37567420 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of SLAMF1 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SLAMF1 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases methylation | ISO | SLAMF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLAMF1 3' UTR and Benzo(a)pyrene results in increased methylation of SLAMF1 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | SLAMF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLAMF1 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLAMF1 mRNA | CTD | PMID:25181051 and PMID:34947998 | buta-1,3-diene | decreases expression | ISO | Slamf1 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of SLAMF1 mRNA | CTD | PMID:29038090 | CGP 52608 | multiple interactions | ISO | SLAMF1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLAMF1 gene] | CTD | PMID:28238834 | chlorpyrifos | increases methylation | EXP | | 6480464 | Chlorpyrifos results in increased methylation of SLAMF1 gene | CTD | PMID:32905263 | copper(II) sulfate | decreases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SLAMF1 mRNA | CTD | PMID:19549813 | D-glucose | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLAMF1 mRNA | CTD | PMID:37567420 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of SLAMF1 mRNA | CTD | PMID:23640034 | dexamethasone | increases expression | ISO | Slamf1 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of SLAMF1 mRNA | CTD | PMID:22733784 | dichloroacetic acid | decreases expression | ISO | Slamf1 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of SLAMF1 mRNA | CTD | PMID:28962523 | dimethylarsinic acid | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA | CTD | PMID:34876320 | dioxygen | decreases expression | ISO | Slamf1 (Mus musculus) | 6480464 | Oxygen deficiency results in decreased expression of SLAMF1 mRNA | CTD | PMID:24205000 | disodium selenite | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of SLAMF1 mRNA | CTD | PMID:18175754 | eugenol | decreases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Eugenol results in decreased expression of SLAMF1 mRNA | CTD | PMID:20713136 | formaldehyde | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SLAMF1 mRNA | CTD | PMID:23649840 | fructose | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLAMF1 mRNA | CTD | PMID:37567420 | glucose | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLAMF1 mRNA | CTD | PMID:37567420 | hydrogen peroxide | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of SLAMF1 mRNA | CTD | PMID:12414654 | lead diacetate | decreases expression | ISO | Slamf1 (Mus musculus) | 6480464 | lead acetate results in decreased expression of SLAMF1 mRNA | CTD | PMID:22609695 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | Lipopolysaccharides inhibits the reaction [Rutin results in increased expression of SLAMF1 protein] | CTD | PMID:28693884 | lipopolysaccharide | multiple interactions | ISO | SLAMF1 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLAMF1 mRNA] | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of SLAMF1 mRNA | CTD | PMID:35811015 | menadione | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of SLAMF1 mRNA | CTD | PMID:12414654 | methotrexate | decreases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of SLAMF1 mRNA | CTD | PMID:24449571 | methylarsonic acid | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA | CTD | PMID:34876320 | nickel atom | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Nickel results in increased expression of SLAMF1 mRNA | CTD | PMID:25583101 | paracetamol | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SLAMF1 mRNA | CTD | PMID:26690555 | protein kinase inhibitor | multiple interactions | ISO | SLAMF1 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLAMF1 mRNA] | CTD | PMID:28003376 | rutin | increases expression | EXP | | 6480464 | Rutin results in increased expression of SLAMF1 protein | CTD | PMID:28693884 | rutin | multiple interactions | EXP | | 6480464 | Lipopolysaccharides inhibits the reaction [Rutin results in increased expression of SLAMF1 protein] | CTD | PMID:28693884 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SLAMF1 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLAMF1 mRNA] | CTD | PMID:35811015 | sodium arsenate | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA | CTD | PMID:34876320 | sodium arsenite | multiple interactions | ISO | Slamf1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA | CTD | PMID:34876320 | tert-butyl hydroperoxide | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of SLAMF1 mRNA | CTD | PMID:12414654 | triptonide | increases expression | ISO | Slamf1 (Mus musculus) | 6480464 | triptonide results in increased expression of SLAMF1 mRNA | CTD | PMID:33045310 | vincristine | increases expression | ISO | SLAMF1 (Homo sapiens) | 6480464 | Vincristine results in increased expression of SLAMF1 mRNA | CTD | PMID:23649840 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
